Skip to main content

Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:

NYSE

Humana Inc., down $9.29 to $130.58

The health insurer reported worse-than-expected third-quarter results and tightened its full-year outlook.

Transocean Ltd., down 21 cents to $29.71

The company said lower demand for rigs is leading to more charges and forcing it to delay its third-quarter financial report.

Genworth Financial Inc., down 25 cents to $8.41

Ratings agency Standard & Poor's cut the financial services company's credit rating to junk status and Moody's is performing a rating review.

Abercrombie & Fitch, down $5.88 to $29.50

The clothing and accessories retailer reported worse-than-expected quarterly results on weaker sales.

Nasdaq

Salix Pharmaceuticals Ltd., down $47.08 to $91.47

The drugmaker reported weak results, cut its outlook and its chief financial officer resigned in the midst of an inventory review.

Sears Holdings Corp., up $10.14 to $42.81

The retailer said it is considering forming a real-estate investment trust and selling up to 300 buildings to boost liquidity.

First Solar Inc., down $6.12 to $50.29

The solar energy company reported weak quarterly results, cut its outlook and said it will not spin off its solar power plants.

Bruker Corp., down $2.98 to $17.91

The scientific equipment maker reported lower-than-expected quarterly results and its financial outlook fell short of forecasts.

This content appears as provided to The Globe by the originating wire service. It has not been edited by Globe staff.

Report an editorial error

Report a technical issue

Tickers mentioned in this story

Study and track financial data on any traded entity: click to open the full quote page. Data updated as of 20/03/26 4:00pm EDT.

SymbolName% changeLast
ANF-N
Abercrombie & Fitch Company
-0.86%87.98
BRKR-Q
Bruker Corp
-0.83%33.35
FSLR-Q
First Solar Inc
-3.42%192.82
GNW-N
Genworth Financial Inc
+0.13%7.99
HUM-N
Humana Inc
+2.07%169.9

Interact with The Globe